Taken together, our results reveal the vital role of miR-152 as a tumor suppressor in human breast cancer by inhibiting both β-catenin and PKM2 expression levels at the post-transcriptional level, and point out the potential clinical application of miRNA-analog for the cancer treatment. Here, PKM is linked to neoplasm.